Metraipolis › archive › dc_3fa4542b9810

Synergistic effect study on the co-delivery of paclitaxel and SiRNA targeting STMN1 based on MPDA nanoparticles in the therapy of ovarian cancer — Europe PMC PMID:41361792

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41361792
DOI
10.1186/s12951-[numero omesso]-8
License (as archived)
solo-consultazione
Archived
2026-11-07T19:14:36.079Z
SHA-256 of the archived text
b441ecda56bbfc528831abc4588a0c262da891e224ff3a7d5f9d154706f0cda3
Stable URL of this page
https://metraipolis.com/documento/dc_3fa4542b9810

How to cite

Synergistic effect study on the co-delivery of paclitaxel and SiRNA targeting STMN1 based on MPDA nanoparticles in the therapy of ovarian cancer — Europe PMC PMID:41361792 — Europe PMC (en), https://europepmc.org/article/MED/41361792 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3fa4542b9810 (Metraipolis archive dc_3fa4542b9810, sha256 b441ecda56bbfc528831abc4588a0c262da891e224ff3a7d5f9d154706f0cda3)
BibTeX
@misc{dc3fa4542b9810,
  title = {Synergistic effect study on the co-delivery of paclitaxel and SiRNA targeting STMN1 based on MPDA nanoparticles in the therapy of ovarian cancer — Europe PMC PMID:41361792},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41361792},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3fa4542b9810; sha256 b441ecda56bbfc528831abc4588a0c262da891e224ff3a7d5f9d154706f0cda3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41361792. Agents can read the archived copy with the MCP tool read_document.